Loading…
Sectoral / Thematic · Aditya Birla Sun Life Mutual Fund · AMFI code 147407Aditya Birla Sun Life Pharma & Healthcare Fund
Disclosed for 86 months, Jul 2019 to Sep 2026.Published as: ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND
Portfolio value
₹1,078 Cr
down ₹25.2 Cr vs Aug 2026
- Stocks held
- 39
- unchanged
- Top 10 weight
- 54.4%
- of the portfolio in its ten largest
- Cash & debt
- 2.1%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 25
Aditya Birla Sun Life Pharma & Healthcare Fund is an active equity fund in the Sectoral / Thematic category from Aditya Birla Sun Life Mutual Fund. In September 2026 it disclosed 39 stocks worth ₹1,078 Cr, down ₹25.2 Cr from Aug 2026. Its largest positions were Torrent Pharmaceuticals Limited (9.3%), Sun Pharmaceutical Industries Limited (8.6%), Apollo Hospitals Enterprise Limited (6.4%); the ten largest together made up 54.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 76.5% of its equity. Cash and debt stood at 2.1%. Compared with Aug 2026 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
69%
Top-10 weight is higher than 69% of peers
Breadth
41%
Holds more stocks than 41% of peers
Cash
29%
Holds more cash than 29% of peers
What these mean: concentration · cash
Holdings in September 2026
Download CSVEvery line the fund disclosed, with the change against Aug 2026. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Torrent Pharmaceuticals Limited | 9.28% | down 0.29 pts | ₹100 Cr | down ₹5.5 Cr | Trimmed |
| Sun Pharmaceutical Industries Limited | 8.61% | down 0.58 pts | ₹92.8 Cr | down ₹8.6 Cr | Trimmed |
| Apollo Hospitals Enterprise Limited | 6.44% | down 0.42 pts | ₹69.4 Cr | down ₹6.2 Cr | Trimmed |
| Cipla Limited | 6.38% | up 1.21 pts | ₹68.7 Cr | up ₹11.8 Cr | Added |
| Aurobindo Pharma Limited | 4.52% | down 0.02 pts | ₹48.7 Cr | down ₹1.3 Cr | Trimmed |
| Sai Life Sciences Limited | 4.49% | up 0.29 pts | ₹48.4 Cr | up ₹2.1 Cr | Added |
| Ajanta Pharma Limited | 4.35% | up 0.12 pts | ₹46.8 Cr | up ₹24 L | Added |
| Mankind Pharma Limited | 3.62% | up 0.20 pts | ₹39 Cr | up ₹1.3 Cr | Added |
| Dr. Lal Path Labs Limited | 3.51% | up 1.40 pts | ₹37.8 Cr | up ₹14.6 Cr | Added |
| Abbott India Limited | 3.26% | up 0.22 pts | ₹35.1 Cr | up ₹1.6 Cr | Added |
| Emcure Pharmaceuticals Limited | 3.21% | up 0.21 pts | ₹34.5 Cr | up ₹1.6 Cr | Added |
| Lupin Limited | 2.94% | down 0.16 pts | ₹31.7 Cr | down ₹2.5 Cr | Trimmed |
| IPCA Laboratories Limited | 2.71% | down <0.01 pts | ₹29.2 Cr | down ₹73 L | Trimmed |
| Gland Pharma Limited | 2.70% | up 0.07 pts | ₹29.1 Cr | up ₹14 L | Held |
| Fortis Healthcare Limited | 2.42% | down 0.37 pts | ₹26.1 Cr | down ₹4.6 Cr | Trimmed |
| Corona Remedies Limited | 2.27% | up 0.10 pts | ₹24.5 Cr | up ₹50 L | Added |
| Divi's Laboratories Limited | 2.24% | up 0.01 pts | ₹24.2 Cr | down ₹46 L | Trimmed |
| Cash, TREPS & receivables | 2.06% | down 1.54 pts | ₹22.2 Cr | down ₹17.5 Cr | Trimmed |
| Procter & Gamble Health Limited | 1.82% | down 0.02 pts | ₹19.6 Cr | down ₹72 L | Trimmed |
| Thyrocare Technologies Limited | 1.76% | down 0.19 pts | ₹18.9 Cr | down ₹2.5 Cr | Trimmed |
| Alkem Laboratories Limited | 1.68% | down 0.01 pts | ₹18.1 Cr | down ₹58 L | Trimmed |
| Jupiter Life Line Hospitals Limited | 1.55% | down 0.21 pts | ₹16.7 Cr | down ₹2.8 Cr | Trimmed |
| Metropolis Healthcare Limited | 1.48% | down 0.07 pts | ₹15.9 Cr | down ₹1.2 Cr | Trimmed |
| Biocon Limited | 1.45% | up 0.27 pts | ₹15.6 Cr | up ₹2.6 Cr | Added |
| Shilpa Medicare Limited | 1.43% | up 0.16 pts | ₹15.4 Cr | up ₹1.4 Cr | Added |
| Piramal Pharma Limited | 1.22% | down 0.02 pts | ₹13.2 Cr | down ₹50 L | Trimmed |
| Dr. Reddy's Laboratories Limited | 1.13% | up 0.10 pts | ₹12.2 Cr | up ₹78 L | Added |
| Anthem Biosciences Limited | 1.13% | down 0.02 pts | ₹12.2 Cr | down ₹49 L | Trimmed |
| Sanofi Consumer Healthcare India Limited | 1.11% | down 0.07 pts | ₹12 Cr | down ₹1.1 Cr | Trimmed |
| Suraksha Diagnostic Limited | 1.10% | up 0.08 pts | ₹11.9 Cr | up ₹56 L | Added |
| Manipal Health Enterprises Ltd | 1.07% | down 0.06 pts | ₹11.5 Cr | down ₹89 L | Trimmed |
| Vijaya Diagnostic Centre Limited | 1.04% | down 0.03 pts | ₹11.2 Cr | down ₹63 L | Trimmed |
| Pfizer Limited | 1.01% | down 0.18 pts | ₹10.9 Cr | down ₹2.3 Cr | Trimmed |
| Natco Pharma Limited | 0.92% | up 0.01 pts | ₹9.9 Cr | down ₹17 L | Trimmed |
| GlaxoSmithKline Pharmaceuticals Limited | 0.83% | down 0.06 pts | ₹9 Cr | down ₹91 L | Trimmed |
| Medi Assist Healthcare Services Ltd | 0.73% | down 0.05 pts | ₹7.9 Cr | down ₹70 L | Trimmed |
| Vinati Organics Limited | 0.69% | down 0.08 pts | ₹7.5 Cr | down ₹1 Cr | Trimmed |
| Syngene International Limited | 0.64% | down 0.05 pts | ₹6.9 Cr | down ₹67 L | Trimmed |
| Max Healthcare Institute Limited | 0.60% | down 0.06 pts | ₹6.5 Cr | down ₹79 L | Trimmed |
| Jubilant Pharmova Limited | 0.60% | up 0.10 pts | ₹6.5 Cr | up ₹93 L | Added |
What changed, Aug 2026 to Sep 2026
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Dr. Lal Path Labs Limitedup ₹14.6 Cr (+1.40% pts)
- Cipla Limitedup ₹11.8 Cr (+1.21% pts)
- Biocon Limitedup ₹2.6 Cr (+0.27% pts)
- Sai Life Sciences Limitedup ₹2.1 Cr (+0.29% pts)
- Abbott India Limitedup ₹1.6 Cr (+0.22% pts)
- Emcure Pharmaceuticals Limitedup ₹1.6 Cr (+0.21% pts)
- Shilpa Medicare Limitedup ₹1.4 Cr (+0.16% pts)
- Mankind Pharma Limitedup ₹1.3 Cr (+0.20% pts)
- Jubilant Pharmova Limitedup ₹93 L (+0.10% pts)
- Dr. Reddy's Laboratories Limitedup ₹78 L (+0.10% pts)
Trimmed Biggest reductions
- Sun Pharmaceutical Industries Limiteddown ₹8.6 Cr (−0.58% pts)
- Apollo Hospitals Enterprise Limiteddown ₹6.2 Cr (−0.42% pts)
- Torrent Pharmaceuticals Limiteddown ₹5.5 Cr (−0.29% pts)
- Fortis Healthcare Limiteddown ₹4.6 Cr (−0.37% pts)
- Jupiter Life Line Hospitals Limiteddown ₹2.8 Cr (−0.21% pts)
- Thyrocare Technologies Limiteddown ₹2.5 Cr (−0.19% pts)
- Lupin Limiteddown ₹2.5 Cr (−0.16% pts)
- Pfizer Limiteddown ₹2.3 Cr (−0.18% pts)
- Aurobindo Pharma Limiteddown ₹1.3 Cr (−0.02% pts)
- Metropolis Healthcare Limiteddown ₹1.2 Cr (−0.07% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Aug 2026, the weight rose most in Pharmaceuticals & Biotechnology (+0.5 pts), and fell most in Healthcare Services (−0.3 pts).
- Pharmaceuticals & Biotechnology76.0% → 76.5%+0.5 pts
- Healthcare Services22.4% → 22.1%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Sep 2023 | Sep 2025 | Mar 2026 | Jun 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 75.2% | 74.7% | 79.8% | 76.8% | 76.0% | 76.5% |
| Healthcare Services | 18.6% | 22.6% | 18.5% | 21.3% | 22.4% | 22.1% |
| Insurance | 1.5% | 1.7% | 0.9% | 1.0% | 0.8% | 0.7% |
| Chemicals & Petrochemicals | 1.3% | 1.0% | 0.7% | 0.9% | 0.8% | 0.7% |
Allocation in Sep 2026change vs Aug 2026
- Pharmaceuticals & Biotechnology (26)76.5%▲ 0.5 pts
- Healthcare Services (11)22.1%▼ 0.3 pts
- Insurance (1)0.7%▼ 0.1 pts
- Chemicals & Petrochemicals (1)0.7%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Sep 2026
2.1%
▼ 1.5 pts vs Aug 2026
- Cash alone
- 2.1%
- cash and net receivables
- A year earlier
- 1.7%
- Sep 2025 · now ▲ 0.4 pts
- Last 12 months
- 1.2% – 3.6%
- lowest to highest · record 13.9% in Jul 2019
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
The last 24 months
| Month | Portfolio value | Stocks | Entered | Exited | Cash | Cash & debt | Turnover |
|---|---|---|---|---|---|---|---|
| Sep 2026 | ₹1,078 Cr | 39 | 0 | 0 | 2.1% | 2.1% | 0% |
| Aug 2026 | ₹1,103 Cr | 39 | 1 | 0 | 3.6% | 3.6% | 2% |
| Jul 2026 | ₹1,074 Cr | 38 | 1 | 1 | 2.4% | 2.4% | 2% |
| Jun 2026 | ₹1,011 Cr | 38 | 1 | 1 | 2.1% | 2.1% | 2% |
| May 2026 | ₹950 Cr | 38 | 0 | 0 | 3.2% | 3.2% | 1% |
| Apr 2026 | ₹901 Cr | 38 | 1 | 0 | 1.4% | 1.4% | 2% |
| Mar 2026 | ₹859 Cr | 37 | 1 | 0 | 2.3% | 2.3% | — |
| Feb 2026 | ₹854 Cr | 36 | 0 | 0 | 1.6% | 1.6% | — |
| Jan 2026 | ₹812 Cr | 36 | 0 | 0 | 2.0% | 2.0% | — |
| Dec 2025 | ₹837 Cr | 36 | 1 | 0 | 1.2% | 1.2% | — |
| Nov 2025 | ₹854 Cr | 35 | 0 | 1 | 2.3% | 2.3% | — |
| Oct 2025 | ₹847 Cr | 36 | 0 | 0 | 3.3% | 3.3% | — |
| Sep 2025 | ₹830 Cr | 36 | 0 | 0 | 1.7% | 1.7% | — |
| Aug 2025 | ₹845 Cr | 36 | 6 | 2 | 2.1% | 2.1% | — |
| Jun 2025 | ₹840 Cr | 32 | 2 | 0 | 1.6% | 1.6% | — |
| May 2025 | ₹814 Cr | 30 | 2 | 0 | 2.1% | 2.1% | — |
| Apr 2025 | ₹818 Cr | 28 | 0 | 0 | 1.8% | 1.8% | — |
| Mar 2025 | ₹815 Cr | 28 | 1 | 0 | 1.2% | 1.2% | — |
| Feb 2025 | ₹755 Cr | 27 | 2 | 1 | 1.4% | 1.4% | — |
| Jan 2025 | ₹815 Cr | 26 | 0 | 2 | 5.7% | 5.7% | — |
| Dec 2024 | ₹890 Cr | 28 | 2 | 1 | 3.5% | 3.5% | — |
| Nov 2024 | ₹854 Cr | 27 | 2 | 1 | 2.2% | 2.2% | — |
| Oct 2024 | ₹882 Cr | 26 | 0 | 0 | 6.4% | 6.4% | — |
| Sep 2024 | ₹888 Cr | 26 | 1 | 1 | 8.0% | 8.0% | — |
For any of the 62 earlier months, choose it in “Portfolio as of” at the top of the page.